Treating Dry Eye Disease: Moving Beyond the Barriers With New Options

555 Canal Street,New Orleans LA 70130

14 November, 2021

Description

This program is intended for AAO attendees only. Hybrid CME Breakfast SymposiumActivity ChairEdward J. Holland, MD Director of Cornea Cincinnati Eye Institute Professor of Clinical Ophthalmology University of Cincinnati Edgewood, KY FacultyMarjan Farid, MD Clinical Professor of Ophthalmology Director of Cornea, Cataract and Refractive Surgery Gavin Herbert Eye Institute University of California, Irvine Irvine, CA Preeya K. Gupta, MD Managing Director Triangle Eye Consultants Durham, NC Terry Kim, MD Professor of Ophthalmology Duke University School of Medicine Chief, Cornea Division Director, Refractive Surgery Service Duke University Eye Center Durham, NC OverviewDry eye disease (DED) is highly prevalent but frequently underdiagnosed and undertreated. DED has a significant impact on patient employment and other activities. Although some risk factors, such as smoking and excessive screen time, are well known, numerous additional risk factors and associations with comorbidities are now considered. While traditional therapies for DED may be helpful, the need for more effective treatments remains. New treatments for DED, with novel mechanisms of action, have become available. In this CME activity, experts in the field will explore the mechanisms of action for conventional versus novel therapies as well the efficacy and safety of new therapies for their ability to treat both the signs and symptoms of DED. This program will include the unique, audience-driven, educational platform Case Choice, where learners select 1 of 2 cases in a pair for discussion. Agenda6:00 AM Registration and Breakfast 6:30 AM Introduction and Pretest Edward J. Holland, MD 6:35 AM Balancing the Burden of Dry Eye Preeya K. Gupta, MD 6:50 AM Unique Mechanisms of New Treatments for Dry Eye Marjan Farid, MD 7:05 AM Focused Treatment of Dry Eye – Improving Signs and Symptoms Terry Kim, MD 7:25 AM Case Choice Moderated by Edward J. Holland, MD 7:45 AM Posttest and Question & Answer 8:00 AM Conclusion Learning ObjectivesUpon successful completion of this activity, participants should be better able to: Recognize the burden of DED in both symptomatic and asymptomatic patient populations to better understand the need for treatment.Differentiate the mechanisms of action for conventional versus novel therapies for DED.Compare the efficacy of conventional dry eye therapies with newer options for treatment.Assess the efficacy and safety of new therapies for their ability to treat both the signs and symptoms of DED.Target AudienceThe intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with DED. This continuing medical education activity is provided by Vindico Medical Education. This activity is supported by an educational grant from Kala Pharmaceuticals. This activity is not affiliated with the official program of AAO 2021. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Vindico Medical Education designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit. In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of accredited content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be mitigated and disclosed to the activity audience. Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance. Privacy Policy Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086